Enjoy complimentary customisation on priority with our Enterprise License!
The microarray analysis market size is forecast to increase by USD 1.45 billion, at a CAGR of 5.4% between 2023 and 2028. The market is experiencing significant growth due to the increasing use of personalized medicine and the rising number of diagnosed cancer cases worldwide. Microarray analysis is a powerful tool used to identify chromosomal deletions, duplications, and aneuploidies by employing DNA probes and hybridization techniques. This process involves fluorescent labeling and laser microscopy for fluorescence measurement. The market is capital-intensive due to the high cost of equipment and reagents. Key applications include the identification of microbial genes and virulence genes, which are crucial in understanding microbial infections and developing targeted therapies. As the field advances, we can expect further innovations in microarray technology, enhancing its diagnostic capabilities and expanding its applications in various industries.
The market encompasses the use of various techniques, including CDNA arrays and oligonucleotide probes, to study gene expression in response to infection. This analysis plays a crucial role in understanding the intricacies of human health and disease, particularly in the context of cytokine genes and their upregulation during infection. One significant application of microarray analysis lies in the study of human fibroblasts and their response to viruses such as cytomegalovirus (CMV) and HIV-1. Infection by these pathogens results in various chromosomal abnormalities, including deletions, duplications, and aneuploidies. Microarray analysis allows researchers to investigate the expression levels of thousands of genes simultaneously, providing valuable insights into the molecular mechanisms underlying these diseases. Microarray analysis is not limited to the study of human diseases. It also plays a pivotal role in the field of microbiology, particularly in the investigation of microbial genes, such as virulence genes and resistance genes.
By utilizing microchip technology, in situ synthesis, and high-density or low-density arrays, researchers can measure the expression levels of these genes and gain a better understanding of the molecular underpinnings of microbial pathogenesis. The process of microarray analysis involves several steps, including DNA probe preparation, hybridization, fluorescent labeling, and fluorescence measurement. DNA probes are designed to specifically bind to target mRNA molecules, which are then captured on the microarray. The probes are labeled with fluorescent dyes, and the microarray is examined using a laser microscope to measure the fluorescence intensity, which correlates with the expression level of the target gene. Microarray analysis has numerous functions in various fields of research, including infectious disease diagnostics and therapeutics. For instance, microbial diagnostic microarrays can be used to detect specific pathogens and identify their virulence factors, enabling rapid and accurate diagnosis. Additionally, microarray analysis can be used to identify potential drug targets and evaluate the efficacy of therapeutic interventions. In conclusion, the microarray analysis market represents a vital tool for researchers in the fields of genetics, microbiology, and infectious disease. By providing insights into gene expression patterns during infection, microarray analysis enables a deeper understanding of the molecular mechanisms underlying various diseases and paves the way for the development of novel diagnostic and therapeutic strategies.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The consumables segment is estimated to witness significant growth during the forecast period. Microarray analysis is a cutting-edge technology utilized in research to identify chromosomal abnormalities such as deletions, duplications, and aneuploidies. This process involves the use of DNA probes that bind to specific target genes on biochips. Subsequently, hybridization occurs, followed by fluorescent labelling and measurement using a laser microscope. This technique is particularly useful in the analysis of microbial genes and virulence genes, providing valuable insights into various diseases, including cancer, mental illnesses, and cardiac diseases.
Get a glance at the market share of various segments Download the PDF Sample
The consumables segment was valued at USD 1.69 billion in 2018. In the realm of personalized medicine, microarray analysis plays a pivotal role in designing targeted treatments for patients. By employing biochips and microarray technology, researchers can expedite their efforts and obtain precise results within a defined timeframe. Furthermore, microarray analysis has gained significant traction in cancer research and pharmacological approaches to disease treatment, extending to oral lesions. Although microarray analysis has not been extensively applied in dentistry research, its potential applications are vast. This technology can potentially aid in the diagnosis and treatment of dental diseases, offering a more efficient and accurate alternative to traditional methods.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 48% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In the global microarray analysis market, North America led in revenue generation in 2023. This dominance can be attributed to the advanced medical research infrastructure and a focus on genomics and proteomics in the region. The healthcare sector in North America has experienced significant innovations, leading to increased utilization of microarray technology. Technological advancements, particularly in robotics and drug formulations, have accelerated the adoption of microarray analysis for gene discovery and DNA sequencing in the region. As a result, North America remains a significant consumer of microarray analysis services, driving market growth in this sector.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The growing use of personalized medicine is notably driving market growth. The market has witnessed significant progress in recent years due to the dedication of various organizations and regulatory bodies. The Food and Drug Administration (FDA) has taken a pivotal role in fostering the production of customized medicines. To spearhead this initiative, the FDA has appointed a Deputy Commissioner for Medical Products and Tobacco, responsible for leading all drug centers focused on personalized medicines. Government entities have also established team leaders for the development of pharmacogenomics and biomarkers. These team leaders collaborate closely with microarray analysis manufacturers to procure the necessary equipment and supplies based on the specific medication requirements for various diseases.
Microarray analysis plays a crucial role in the detection and identification of toxic compounds, antibodies, bacteria, viruses, antibiotics, vaccines, and diagnostics. By utilizing microarray analysis, researchers and pharmaceutical companies can gain valuable insights into the mechanisms of diseases and develop targeted therapies, ultimately improving patient outcomes. Thus, such factors are driving the growth of the market during the forecast period.
Growing number of cancer cases worldwide is the key trend in the market. The field of gene expression analysis has gained significant attention in the scientific community due to its potential in understanding the complex biological processes involved in various diseases, including infections. One area of focus has been the study of cytokine genes, which play crucial roles in the immune response. For instance, human fibroblasts exposed to Cytomegalovirus (CMV) or HIV-1 display upregulated expressions of these genes. Cytokine genes are essential in the regulation of immune responses, and their mRNA responses can be analyzed using advanced technologies such as cDNA arrays. These arrays enable the simultaneous measurement of the expression levels of thousands of genes, providing valuable insights into the molecular mechanisms underlying infection and disease progression. CD4+ T cells, a critical component of the adaptive immune system, have been extensively studied in the context of HIV-1 infection. The upregulation of specific cytokine genes in CD4+ T cells can help identify potential therapeutic targets for treating HIV-1 infection. Similarly, the study of gene expression in response to other infections, such as CMV, can provide insights into the host-pathogen interaction and help develop effective antiviral therapies.
Overall, the analysis of gene expression using microarray technology offers a powerful tool for understanding the intricacies of biological systems and developing targeted therapeutic interventions. In conclusion, the study of gene expression, particularly cytokine genes, plays a vital role in understanding the immune response to various infections. Microarray analysis, using technologies such as cDNA arrays, enables the simultaneous measurement of the expression levels of thousands of genes, providing valuable insights into the molecular mechanisms underlying infection and disease progression. This knowledge can be leveraged to develop effective therapeutic interventions and improve patient outcomes. Thus, such trends will shape the growth of the market during the forecast period.
A capital-intensive market is a major challenge that affects the growth of the market. Microarray analysis is a significant market with applications in various sectors, particularly in the field of medical research. The technology, which allows for the analysis of genetic makeup and gene functions in organisms, has been instrumental in advancing prognostics and personalized treatments in pharmacogenomics and theranostics. However, the high costs associated with this technology have been a deterrent for companies, investors, and end-users. The capital-intensive nature of microarray analysis has led to skepticism regarding the returns on investment.
Furthermore, the accuracy of microarray analysis can be compromised due to the limited genetic sequence coverage and low dynamic range of existing microarrays. Despite these challenges, microarray analysis continues to be a valuable tool in understanding new genes and their functions, contributing to the development of innovative diagnostic and therapeutic approaches. Hence, the above factors will impede the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Agilent Technologies Inc. - The company offers microarray analysis such as Agilent SurePrint G3 Microarrays, which are designed for various applications including gene expression and genotyping.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market encompasses the use of various techniques, including CDNA arrays and oligonucleotide probes, to study gene expression in response to infection. This analysis plays a crucial role in understanding the intricacies of human health and disease, particularly in the context of cytokine genes and their upregulation during infection. One significant application of microarray analysis lies in the study of human fibroblasts and their response to viruses such as cytomegalovirus (CMV) and HIV-1. Infection by these pathogens results in various chromosomal abnormalities, including deletions, duplications, and aneuploidies. Microarray analysis allows researchers to investigate the expression levels of thousands of genes simultaneously, providing valuable insights into the molecular mechanisms underlying these diseases. Microarray analysis is not limited to the study of human diseases. It also plays a pivotal role in the field of microbiology, particularly in the investigation of microbial genes, such as virulence genes and resistance genes. By utilizing microchip technology, in situ synthesis, and high-density or low-density arrays, researchers can measure the expression levels of these genes and gain a better understanding of the molecular underpinnings of microbial pathogenesis. The process of microarray analysis involves several steps, including DNA probe preparation, hybridization, fluorescent labeling, and fluorescence measurement. DNA probes are designed to specifically bind to target mRNA molecules, which are then captured on the microarray.
The probes are labeled with fluorescent dyes, and the microarray is examined using a laser microscope to measure the fluorescence intensity, which correlates with the expression level of the target gene. Microarray analysis has numerous functions in various fields of research, including infectious disease diagnostics and therapeutics. For instance, microbial diagnostic microarrays can be used to detect specific pathogens and identify their virulence factors, enabling rapid and accurate diagnosis. Additionally, microarray analysis can be used to identify potential drug targets and evaluate the efficacy of therapeutic interventions. In conclusion, the microarray analysis market represents a vital tool for researchers in the fields of genetics, microbiology, and infectious disease. By providing insights into gene expression patterns during infection, microarray analysis enables a deeper understanding of the molecular mechanisms underlying various diseases and paves the way for the development of novel diagnostic and therapeutic strategies.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
142 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.4% |
|
Market Growth 2024-2028 |
USD 1.45 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
5.0 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 48% |
|
Key countries |
US, Germany, UK, Canada, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Agilent Technologies Inc., Applied Microarrays Inc., Arrayit Corp., Bio Rad Laboratories Inc., BioMerieux SA, Danaher Corp., DiaSorin SpA, fzmb GmbH, GENOMICA S.A.U., Illumina Inc., INNOPSYS, LABORATORIOS INIBSA S.A., Merck KGaA, Microarrays Inc., Perkin Elmer Inc., QIAGEN N.V., Scienion AG, Sentinel CH. SpA, Thermo Fisher Scientific Inc., and Win Semiconductor |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Service
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
